This content is machine translated Prevention and early detection: breast and ovarian cancer Screening strategies, risk genetics and guideline recommendations Breast cancer is the most common cancer in women worldwide – and also the one with the greatest potential for reducing mortality through structured screening. A German long-term study presented...…
View Post 15 min This content is machine translated Diagnostics, differentiation and multimodal therapy Vulvar diseases and vulvodynia Vulvar pain, itching and burning are common complaints – and often misunderstood. An estimated 10 to 28 percent of all women suffer from vulvodynia in the course of their lives;...…
View Post 15 min This content is machine translated Perimenopausal depression, PMDS and tokophobia Psychosomatics and mental health in gynecology Mental illnesses in women are common, serious – and systematically underdiagnosed in gynecological practice. The tripled risk of depression in the perimenopause, PMDS (premenstrual dysphoric disorder), which is recognized as...…
View Post 9 min This content is machine translated Polycystic ovary syndrome 2025/2026 New pathophysiology, updated diagnostics and the age of incretin mimetics With a prevalence of 8-13%, polycystic ovary syndrome (PCOS) is the most common endocrine disorder in women of reproductive age – and yet up to 70% of those affected remain...…
View Post 11 min This content is machine translated New evidence on descensus, urinary incontinence and the future of reconstruction Urogynecology and pelvic floor surgery 2026 Urogynecology and reconstructive pelvic floor surgery are in a phase of upheaval: the ban on transvaginal polypropylene mesh kits in many countries has fundamentally changed the surgical strategy and provided...…
View Post 12 min This content is machine translated Current evidence, risk classes and new counseling options Hormonal contraception and cardiovascular risk Over 247 million women worldwide use hormonal contraception – the majority with combined oral contraceptives (COCs). This prevalence is accompanied by an ongoing medical responsibility: venous thromboembolism, ischemic strokes and...…
View Post 13 min This content is machine translated New WHO guideline, updated stimulation protocols, focus on PGT-A Fertility and reproductive medicine 2026 The year 2025 has brought several landmark documents to reproductive medicine: the first WHO guideline on the prevention, diagnosis and treatment of infertility, the major update of the ESHRE guideline...…
View Post 14 min This content is machine translated New approvals, current study data and ADC development Antibody-drug conjugates in gynecologic oncology Antibody-drug conjugates (ADCs) have profoundly changed gynecological oncology in a very short space of time. Within just two years, three ADCs – mirvetuximab soravtansine, tisotumab vedotin and trastuzumab deruxtecan –...…
View Post 22 min This content is machine translated Cervical Cancer HPV prevention, screening innovation and sentinel lymph node biopsy Cervical cancer is one of the most preventable cancers worldwide – and yet over 340,000 women die from it every year. In the period 2025/2026, several developments have fundamentally changed...… CME-Test
View Post 5 min This content is machine translated Asthma during pregnancy Up to 40% suffer worsening of symptoms during pregnancy Asthma is one of the most common chronic diseases during pregnancy. Despite this, targeted research in this area remains relatively limited and translation into optimal maternal care remains a challenge....…
View Post 7 min This content is machine translated HER2+ metastatic breast cancer New therapeutic standards with SHR-A 1811 This year’s ESMO Congress 2025 once again offered a wide range of new data on the treatment of HER2-positive breast cancer, including the interim analysis of the phase 3 HORIZON-Breast01...…
